Back to top Open menu arrow
The Journal of Clinical Psychiatry The Journal of Clinical Psychiatry

The Journal of
Clinical Psychiatry
Access icon

This article is available to members only. Please enjoy the abstract for free. Subscribe for instant access to the full article.

This content is restricted to subscribers

Continue Reading...

Did you know members enjoy unlimited free PDF downloads as part of their subscription? Subscribe today for instant access to this article and our entire library in your preferred format. Alternatively, you can purchase the PDF of this article individually.

Subscribe Now

Already a member? Login

Purchase PDF for $40

Members enjoy free PDF downloads on all articles. Join today

  1. Department of Psychiatry, Massachusetts General Hospital, Boston
  2. McLean Hospital, Belmont, Massachusetts
  3. Department of Psychiatry, Harvard Medical School, Boston, Massachusetts
  4. Corresponding Author: Michal McDowell, MD, MPH, 15 Parkman St, WACC 812, Boston, MA 02114 ([email protected]).
  5. The Fenway Institute, Fenway Health, Boston, Massachusetts
  6. The Fenway Institute, Fenway Health, Boston, Massachusetts
  7. Department of Psychiatry, Harvard Medical School, Boston, Massachusetts
  8. Department of Psychiatry, Massachusetts General Hospital, Boston
  9. The Fenway Institute, Fenway Health, Boston, Massachusetts
  10. Department of Psychiatry, Harvard Medical School, Boston, Massachusetts
  11. McLean Hospital, Belmont, Massachusetts
  12. Department of Psychiatry, Harvard Medical School, Boston, Massachusetts
  13. Department of Health Care Policy, Harvard Medical School, Boston, Massachusetts
  14. McLean Hospital, Belmont, Massachusetts
  15. Department of Psychiatry, Harvard Medical School, Boston, Massachusetts
  16. Department of Health Care Policy, Harvard Medical School, Boston, Massachusetts
  17. Department of Psychiatry, Massachusetts General Hospital, Boston
  18. The Fenway Institute, Fenway Health, Boston, Massachusetts
  19. Department of Psychiatry, Harvard Medical School, Boston, Massachusetts
  1. Hughto JMW, Quinn EK, Dunbar MS, et al. Prevalence and co-occurrence of alcohol, nicotine, and other substance use disorder diagnoses among US transgender and cisgender adults. JAMA Netw Open. 2021;4(2):e2036512. PubMed CrossRef
  2. Reisner SL, Biello KB, White Hughto JM, et al. Psychiatric diagnoses and comorbidities in a diverse, multicity cohort of young transgender women: baseline findings from project lifeskills. JAMA Pediatr. 2016;170(5):481–486. PubMed CrossRef
  3. Rowe C, Santos GM, McFarland W, et al. Prevalence and correlates of substance use among trans female youth ages 16–24 years in the San Francisco Bay Area. Drug Alcohol Depend. 2015;147:160–166. PubMed CrossRef
  4. Jun HJ, Webb-Morgan M, Felner JK, et al. Sexual orientation and gender identity disparities in substance use disorders during young adulthood in a United States longitudinal cohort. Drug Alcohol Depend. 2019;205:107619. PubMed CrossRef
  5. USTS Reports [Internet]. US Trans Survey website. https://www.ustranssurvey.org/reports. 2015. Cited February 25, 2021.
  6. Williams EC, Frost MC, Rubinsky AD, et al. Patterns of alcohol use among transgender patients receiving care at the Veterans Health Administration: overall and relative to nontransgender patients. J Stud Alcohol Drugs. 2021;82(1):132–141. PubMed CrossRef
  7. Talley AE, Hughes TL, Aranda F, et al. Exploring alcohol-use behaviors among heterosexual and sexual minority adolescents: intersections with sex, age, and race/ethnicity. Am J Public Health. 2014;104(2):295–303. PubMed CrossRef
  8. Gonzales G, Przedworski J, Henning-Smith C. Comparison of health and health risk factors between lesbian, gay, and bisexual adults and heterosexual adults in the United States: results from the national health interview survey. JAMA Intern Med. 2016;176(9):1344–1351. PubMed CrossRef
  9. McGeough BL, Aguilera A, Capriotti MR, et al. Understanding co-occurring depression symptoms and alcohol use symptoms among cisgender sexual minority women. J Gay Lesbian Soc Serv. 2021;33(4):427–450. CrossRef
  10. Diamant AL, Wold C, Spritzer K, et al. Health behaviors, health status, and access to and use of health care: a population-based study of lesbian, bisexual, and heterosexual women. Arch Fam Med. 2000;9(10):1043–1051. PubMed CrossRef
  11. McCabe SE, Hughes TL, Bostwick WB, et al. Sexual orientation, substance use behaviors and substance dependence in the United States. Addiction. 2009;104(8):1333–1345. PubMed CrossRef
  12. Coulter RWS, Jun HJ, Calzo JP, et al. Sexual-orientation differences in alcohol use trajectories and disorders in emerging adulthood: results from a longitudinal cohort study in the United States. Addiction. 2018;113(9):1619–1632. PubMed CrossRef
  13. Stanton AM, Batchelder AW, Kirakosian N, et al. Differences in mental health symptom severity and care engagement among transgender and gender diverse individuals: findings from a large community health center. PLoS One. 2021;16(1):e0245872. PubMed CrossRef
  14. Batchelder AW, Stanton AM, Kirakosian N, et al. Mental health and substance use diagnoses and treatment disparities by sexual orientation and gender in a community health center sample. LGBT Health. 2021;8(4):290–299. PubMed CrossRef
  15. Reisner SL, Pardo ST, Gamarel KE, et al. Substance use to cope with stigma in healthcare among us female-to-male trans masculine adults. LGBT Health. 2015;2(4):324–332. PubMed CrossRef
  16. McCabe SE, Bostwick WB, Hughes TL, et al. The relationship between discrimination and substance use disorders among lesbian, gay, and bisexual adults in the United States. Am J Public Health. 2010;100(10):1946–1952. PubMed CrossRef
  17. Johnson EEH, Wilder SMJ, Andersen CVS, et al. Trauma and alcohol use among transgender and gender diverse women: an examination of the stress-buffering hypothesis of social support. J Prim Prev. 2021;42(6):567–581. PubMed CrossRef
  18. Scroggs B, Love HA. Understanding sexual and gender minority substance use through latent profiles of ecological systems. Subst Abus. 2022;43(1):640–648. PubMed CrossRef
  19. Wolfe HL, Biello KB, Reisner SL, et al. Transgender-related discrimination and substance use, substance use disorder diagnosis and treatment history among transgender adults. Drug Alcohol Depend. 2021;223:108711. PubMed CrossRef
  20. Medication for the treatment of alcohol use disorder: a brief guide. Substance Abuse and Mental Health Services Administration. National Institute on Alcohol Abuse and Alcoholism. 2015. https://store.samhsa.gov/system/files/sma15-4907.pdf
  21. Pharmacological Treatment of Patients With Alcohol Use Disorder. Psychiatry Online. 2018. Cited February 8, 2021. https://psychiatryonline.org/doi/book/10.1176/appi.books.9781615371969
  22. Kelly JF, Humphreys K, Ferri M. Alcoholics Anonymous and other 12‐step programs for alcohol use disorder. Cochrane Database of Systematic Reviews. Cochrane Library. 2020. Cited February 4, 2022. https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD012880.pub2/full
  23. Ray LA, Bujarski S, Grodin E, et al. State-of-the-art behavioral and pharmacological treatments for alcohol use disorder. Am J Drug Alcohol Abuse. 2019;45(2):124–140. PubMed CrossRef
  24. Key Substance Use and Mental Health Indicators in the United States: Results from the 2020 National Survey on Drug Use and Health. Substance Abuse and Mental Health Services Administration; 2021:156.
  25. TIP 42: Substance Use Treatment for Persons With Co-Occurring Disorders. Substance Abuse and Mental Health Services Administration. 2020. Cited November 28, 2022. https://store.samhsa.gov/product/tip-42-substance-use-treatment-persons-co-occurring-disorders/PEP20-02-01-004
  26. Kroenke K, Spitzer RL, Williams JBW. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. 2001;16(9):606–613. PubMed CrossRef
  27. Mental Health Medications. NAMI: National Alliance on Mental Illness. Cited December 13, 2022.  https://www.nami.org/About-Mental-Illness/Treatments/Mental-Health-Medications
  28. STROBE: STrengthening the Reporting of OBservational studies in Epidemiology. Cited December 11, 2022. https://www.strobe-statement.org/
  29. 2020 NSDUH Detailed Tables. CBHSQ Data. Substance Abuse and Mental Health Services Administration. 2020. Cited February 4, 2022. https://www.samhsa.gov/data/report/2020-nsduh-detailed-tables
  30. Leung JG, Narayanan PP, Markota M, et al. Assessing naltrexone prescribing and barriers to initiation for alcohol use disorder: a multidisciplinary, multisite survey. Front Psychiatry. 2022;13:856938. PubMed CrossRef
  31. Williams ND, Turpin RE, Akré EL, et al. Disparities in mental health care access among persons differing in sexual identity: nationally representative findings. Psychiatr Serv. 2022;73(4):456–459. PubMed CrossRef
  32. Perlson JE, Walters OC, Keuroghlian AS. Envisioning a future for transgender and gender-diverse people beyond the DSM. Br J Psychiatry. 2021;219(3):471–472. PubMed CrossRef
  33. Wu CA, Keuroghlian AS. Moving beyond psychiatric gatekeeping for gender-affirming surgery. JAMA Surg. 2023;158(3):231–232. PubMed CrossRef
Purchase PDF for $40

Members enjoy free PDF downloads on all articles. Join today

Save Save

Share Share

Cite Cite

Celebrating
85 Years

Read the Journal of Clinical Psychiatry

Subscribe to read
more articles

Subscribe now